ESC 365 - Exploring the link between type 2 diabetes and cardiovascular disease.

Open Access

Exploring the link between type 2 diabetes and cardiovascular disease.

Session: The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care

Topic: Pharmacotherapy

Speaker: Professor M. Petrie (Glasgow, GB)

Sponsored by Novo Nordisk A/S

Event: ESC CONGRESS 2020 - The Digital Experience

Congress Presentation

About the speaker

Professor Mark Petrie

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

22 presentations

1 follower

4 more presentations in this session

Welcome and introduction.

Speaker: Professor M. Petrie (Glasgow, GB)

Shifting clinical guidelines in type 2 diabetes and cardiovascular disease.

Speaker: Professor S. Verma (Toronto, CA)

Translating knowledge into clinical practice.

Speaker: Professor M. Kosiborod (Kansas City, US)

Panel discussion.

Speaker: Professor M. Petrie (Glasgow, GB) Professor S. Verma (Toronto, CA) Professor M. Kosiborod (Kansas City, US)

Access the full session

The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care

Speakers: Professor M. Petrie, Professor M. Petrie, Professor S. Verma, Professor M. Kosiborod, Professor M. Petrie...

About the event

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Congress

Related content

ACNAP Premium Access

Discussion: Shared decision-making: how, what, and why.

23 May 2022

Open Access

Should we encourage earlier and broader use of combination therapies in dyslipidemia?

28 August 2021

Open Access

Influenza and cardiovascular disease.

27 August 2021

ESC 365 is supported by